DENTSPLY International (XRAY) : Beacon Investment Advisory Services scooped up 14 additional shares in DENTSPLY International during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 9, 2016. The investment management firm now holds a total of 11,060 shares of DENTSPLY International which is valued at $676,430.DENTSPLY International makes up approximately 0.30% of Beacon Investment Advisory Services’s portfolio.
Other Hedge Funds, Including , Advantus Capital Management Inc reduced its stake in XRAY by selling 3,402 shares or 12.73% in the most recent quarter. The Hedge Fund company now holds 23,317 shares of XRAY which is valued at $1,426,068. DENTSPLY International makes up approx 0.04% of Advantus Capital Management Inc’s portfolio.Teachers Advisors Inc reduced its stake in XRAY by selling 10,061 shares or 3.28% in the most recent quarter. The Hedge Fund company now holds 296,707 shares of XRAY which is valued at $18,321,657. DENTSPLY International makes up approx 0.03% of Teachers Advisors Inc’s portfolio.Tortoise Investment Management reduced its stake in XRAY by selling 350 shares or 23.33% in the most recent quarter. The Hedge Fund company now holds 1,150 shares of XRAY which is valued at $71,013. DENTSPLY International makes up approx 0.03% of Tortoise Investment Management’s portfolio. Washington Trust Co sold out all of its stake in XRAY during the most recent quarter. The investment firm sold 12,329 shares of XRAY which is valued $761,316.Ownership Capital B.v. reduced its stake in XRAY by selling 137,141 shares or 19.63% in the most recent quarter. The Hedge Fund company now holds 561,322 shares of XRAY which is valued at $34,661,634. DENTSPLY International makes up approx 6.04% of Ownership Capital B.v.’s portfolio.
DENTSPLY International closed down -0.74 points or -1.20% at $61.16 with 10,67,732 shares getting traded on Friday. Post opening the session at $61.81, the shares hit an intraday low of $61.09 and an intraday high of $61.96 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, DENTSPLY International reported $0.69 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on May 6, 2016. Analyst had a consensus of $0.62. The company had revenue of $772.60 million for the quarter, compared to analysts expectations of $778.36 million. The company’s revenue was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 EPS.
Many Wall Street Analysts have commented on DENTSPLY International. Company shares were Reiterated by Barrington Research on May 13, 2016 to “Outperform”, Firm has raised the Price Target to $ 68 from a previous price target of $62 .DENTSPLY International was Downgraded by Morgan Stanley to ” Equal-Weight” on Mar 24, 2016. DENTSPLY International was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016.
DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.